RecruitingNCT06733753
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules
Ultrasound-guided Thermal Ablation for Bethesda III/IV Thyroid Nodules: A Multicenter Study
Sponsor
Chinese PLA General Hospital
Enrollment
600 participants
Start Date
Dec 9, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To evaluate the long-term outcomes of ultrasound-guided thermal ablation for Bethesda III/IV thyroid nodules
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- confirmation of Bethesda III or IV on fine- needle aspiration and negative on Braf V600E test
- no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
- refusal or ineligibility for surgery
- follow-up time ≥12 months
Exclusion Criteria4
- follicular neoplasm or malignancy findings on biopsy
- no suspicious of malignancy in US
- patients with contra-lateral vocal cord paralysis
- follow- up time less than 12 months
Interventions
PROCEDUREultrasound-guided thermal ablation
microwave ablation, radio frequency ablation, laser ablation
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06733753
Related Trials
Postoperative Hypocalcemia After Thyroidectomy
NCT074280571 location
Active Surveillance for Bethesda IV Thyroid Nodules
NCT073706751 location
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
NCT072871762 locations
A Study of Multiparametric Ultrasound Imaging Methods
NCT072702377 locations
Decision Aid and Thyroid Nodules Management
NCT052648571 location